Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3323 ARTÍCULOS , VIENDO DEL 2221 AL 2235

Do neurologists make a difference in Parkinson disease care?

Burke JF, Albin RL.

Neurology. 2011 Aug 30;77(9):e52-3. doi: 10.1212/WNL.0b013e31822f48fb.

Neuronal differentiation of human mesenchymal stromal cells increases their resistance to Aβ42 aggregate toxicity

Cecchi C, Evangelisti E, Cascella R, Zampagni M, Benvenuti S, Luciani P, Deledda C, Cellai I, Wright D, Saccardi R, Peri A, Stefani M.

J Alzheimers Dis. 2011;27(3):651-64. doi: 10.3233/JAD-2011-110590.

Emotional dysfunction in Parkinson's disease

Blonder LX, Slevin JT.

Behav Neurol. 2011;24(3):201-17. doi: 10.3233/BEN-2011-0329.

Dyskinetic Parkinson's disease patients demonstrate motor abnormalities off medication

Stevenson JK, Talebifard P, Ty E, Oishi MM, McKeown MJ.

Exp Brain Res. 2011 Oct;214(3):471-9. doi: 10.1007/s00221-011-2845-2. Epub 2011 Aug 30.

The CDK inhibitors in cancer research and therapy

Cicenas J, Valius M.

J Cancer Res Clin Oncol. 2011 Oct;137(10):1409-18. doi: 10.1007/s00432-011-1039-4. Epub 2011 Aug 30.

The serotonergic system in Parkinson's disease

Huot P, Fox SH, Brotchie JM.

Prog Neurobiol. 2011 Oct;95(2):163-212. doi: 10.1016/j.pneurobio.2011.08.004. Epub 2011 Aug 22.

Mitochondrial disease in pregnancy: a systematic review

Say RE, Whittaker RG, Turnbull HE, McFarland R, Taylor RW, Turnbull DM.

Obstet Med. 2011 Sep;4(3):90-4. doi: 10.1258/om.2011.110008. Epub 2011 Jun 23.

Sleep-wake changes in the premotor stage of Parkinson disease

Iranzo A.

J Neurol Sci. 2011 Nov 15;310(1-2):283-5. doi: 10.1016/j.jns.2011.07.049. Epub 2011 Aug 30.

Unilateral GPi-DBS as a treatment for levodopa-induced respiratory dyskinesia in Parkinson disease

Oyama G, Foote KD, Iyer SS, Zeilman P, Hwynn N, Jacobson CE, Malaty IA, Fernandez HH, Rodriguez RL, Okun MS.

Neurologist. 2011 Sep;17(5):282-5. doi: 10.1097/NRL.0b013e318217367b.

A coincidental case of young-onset Parkinson disease and multiple sclerosis

Damásio J, Ramos C, Valdemar L, da Silva AM, Magalhães M.

Neurologist. 2011 Sep;17(5):286-8. doi: 10.1097/NRL.0b013e318224ed84.

Continuous drug delivery in early- and late-stage Parkinson's disease as a strategy for avoiding dyskinesia induction and expression

Jenner P, McCreary AC, Scheller DK.

J Neural Transm (Vienna). 2011 Dec;118(12):1691-702. doi: 10.1007/s00702-011-0703-9. Epub 2011 Sep 1.

Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation

Iravani MM, Jenner P.

J Neural Transm (Vienna). 2011 Dec;118(12):1661-90. doi: 10.1007/s00702-011-0698-2. Epub 2011 Sep 1.

[A 84-year-old man with apraxia and parkinsonism on his left side,who became bedridden for 6 years]

Takanashi M, Funabe S, Murayama S, Yokochi M.

Brain Nerve. 2011 Aug;63(8):901-8, 909-11.

Prevalence of malnutrition in Parkinson's disease: a systematic review

Sheard JM, Ash S, Silburn PA, Kerr GK.

Nutr Rev. 2011 Sep;69(9):520-32. doi: 10.1111/j.1753-4887.2011.00413.x.

The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease

Surmeier DJ, Guzman JN, Sanchez-Padilla J, Schumacker PT.

Neuroscience. 2011 Dec 15;198:221-31. doi: 10.1016/j.neuroscience.2011.08.045. Epub 2011 Aug 25.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias